|
|||||
|
|
Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab |
|
| Authors: | Jeeyun Lee Yong Sang Hong Jung Yong Hong Se Won Han Tae Won Kim Hye Jin Kang Tae You Kim Kyu-pyo Kim Suk Hyung Kim In-Gu Do Kyoung-Mee Kim Insuk Sohn Se Hoon Park Joon Oh Park Ho Yeong Lim Yong Beom Cho Woo Yong Lee Seong Hyeon Yun Hee Cheol Kim Young Suk Park Won Ki Kang |
| Affiliation: | 1. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong Gangnam-gu, Seoul, 135-710, Korea 2. Department of Oncology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea 3. Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea 4. Division of Hematology/Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea 5. Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 6. Samsung Cancer Research Institute, Samsung Medical Center, Seoul, South Korea 7. Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |